Profil
Marc Abrams worked as a Senior Vice President-Discovery Research at Dicerna Pharmaceuticals, Inc. from 2021 to 2023.
He received his graduate degree from the University of Rochester, his doctorate from Thomas Jefferson University, and his undergraduate degree from Drexel University.
Anciens postes connus de Marc Abrams
| Sociétés | Poste | Fin |
|---|---|---|
| DICERNA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 02/01/2023 |
Formation de Marc Abrams
| Rochester Christian University | Graduate Degree |
| Thomas Jefferson University | Doctorate Degree |
| Drexel University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Dicerna Pharmaceuticals, Inc.
 Dicerna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dicerna Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing and commercializing medicines that are designed to leverage ribonucleic acid interference (RNAi) to selectively silence genes that cause or contribute to disease. The firm uses its proprietary GalXC RNAi technology platform to build a pipeline in these therapeutic areas. The company was founded by Douglas M. Fambrough III, Mark A. Behlke, Roberto Guerciolini, James Craig Jenson, and John J. Rossi in October 2006 and is headquartered in Lexington, MA. | Health Technology |
